SUMMARY
be effective in a rapid intubation sequence. Since this agent also has a shorter duration of action than any other clinically available opioid, the depressant effects on the neonate might be expected to persist for an acceptably short period.
CASE REPORT
An 18-year-old patient known to have aortic stenosis presented for antenatal care with a 23-week concealed pregnancy. During the second trimester she began to complain of dizzy spells and breathlessness induced by walking up slight inclines or against the wind. The fetus appeared to be normal: there was no evidence of intrauterine growth retardation and antenatal cardiotocography did not reveal any evidence of fetal hypoxia.
By the 34th week of pregnancy the patient was incapacitated by dizziness associated with systolic hypotension (50 mm Hg), and suffered several "fainting" attacks. A Doppler ultrasound study estimated the systolic gradient across the aortic valve to be approximately 70 mm Hg. It was decided to proceed to Caesarean section under general anaesthesia using an opioid to obtund the responses to intubation and surgery.
Anaesthesia was induced using etomidate 12 mg and alfentanil 1.75 mg (35 ng kg" 1 ). Muscle paralysis was achieved with suxamethonium in the first instance, followed by pancuronium 5 mg. The lungs were ventilated artificially and anaesthesia maintained with 67% nitrous oxide in oxygen and 0.5 % halothane.
Twelve minutes after the induction of anaesthesia (2 min after uterine incision) an apnoeic infant weighing 2040 g was delivered. The placenta was normal, and the liquor was not meconium stained. Muscle tone was poor and the baby did not respond to stimuli. One minute after delivery a tracheal tube was inserted and artificial ventilation instituted. The Apgar score was 2 (table I). After 1 min of controlled ventilation the baby was observed to be pink, with a heart rate of 140 beat min" 1 , but remained apnoeic, atonic and unresponsive (Apgar score 4).
Eight minutes after delivery, naloxone 100 ug (50 |ig kg" 1 ) was given. Almost immediately the infant became alert and commenced spontaneous breathing (Apgar score 10). However, artificial ventilation was continued electively for 3 days because of mild respiratory distress syndrome. The baby's further progress was straightforward, and she has developed normally.
The anaesthetic technique was successful in preventing a response to intubation; maternal arterial pressure remained at its preoperative value (90/60 mm Hg) throughout induction. After induction, arterial pressure decreased briefly to 70/50 mm Hg, but returned to the preoperative value before the abdominal incision was made. During the 5-min period between incision and delivery the arterial pressure remained unchanged.
After delivery the systolic arterial pressure remained within the range 90-100 mm Hg.
Five months after the birth of her baby, and when symptom free, the mother underwent cardiac catheterization. An aortic valve systolic gradient of 100 mm Hg, and a peak left ventricular pressure of 195 mm Hg, were recorded. The aortogram showed a thickened, immobile, deformed valve and some supravalvular narrowing. There was grade 2/4 aortic regurgitation and good left ventricular function. The ECG was normal.
Blood sampling
At delivery of the infant, maternal and cord blood samples were taken for synchronous estimations of alfentanil concentrations and plasma protein binding. A further specimen of blood was taken from the baby 48 min after delivery.
Plasma concentrations were estimated by radioimmunoassay (Bower and Hull, 1982) . Plasma protein binding of alfentanil was estimated in both neonatal and maternal blood using an equilibrium dialysis technique (Bower, 1981) (table II) .
Protein binding and free drug concentrations
Free drug concentrations were calculated from total plasma concentrations by means of the expression:
[FREE] = [TOTAL] x (1 -bound fraction) It was found that, although the maternal total concentration was approximately diree times that in the neonate, free concentrations were very similar (table II) .
Protein binding of alfentanil in neonates
Since the above difference in maternal and neonatal binding ratios could conceivably have been the result of some individual abnormality in . Free drug on each side of the membrane is also in equilibrium with bound drug in a ratio governed by the corresponding association constant. Thus when the two proteins have differing concentrations or association constants, or both, the bound concentrations will differ also. Since the total drug concentration is the sum of bound and free fractions, this value may be different in the two solutions. If the placenta were freely permeable to alfentanil, with rapid equilibration, then the free concentrations in mother and infant would be expected to be equal. Taking the observed maternal concentration of 67 ng ml" 1 , of which 12 % was unbound, the free concentration can be calculated to be 8.04 ng ml"
1 . Similarly, of the simultaneously measured neonatal concentration (22.4 ng mg-1 ) 23 % was unbound, yielding a free concentration of 7.4 ng ml"
1 . The close similarity between maternal and neonatal free concentrations supports the hypothesis that alfentanil equilibrates freely and rapidly across the placenta.
The mean percentage binding of 72.66 % (SEM 1.61) in neonatal blood (table III) may be compared with the value of 88.65% (SEM 0.45) found in the blood of 42 healthy adult subjects (Bower and Hull, 1982) . In both groups, protein binding was estimated using the same technique, in the same laboratory, by the same investigator. The mean values differed significantly (P < 0.001).
These results differ from the data obtained by Meistelman and his colleagues (Meistelman et al., 1985) , who estimated the bound percentage of alfentanil in the blood of nine infants to be 62.9 %. Since they also estimated maternal protein binding to be only 82.5%, but with a similar coefficient of variation, the differences from our data are likely to be attributable to methodological factors.
In the same study, Meistelman's group also showed that the neonatal concentrations of alpha,-acid-glycoprotein (AGP) are only some 44% of adult values. It has been suggested (Meuldermans, Hurkmans and Heykants, 1982) that AGP is responsible for at least part of the protein binding characteristics of alfentanil. Therefore, it is possible, as proposed by Meistelman, that lower protein binding in neonates is the result of this difference in AGP concentration.
It was disturbing to note that the infant in our case was not only apnoeic with bradycardia and dusky extremities, but also "floppy" with no evidence of reflex irritability. Neonatal hypotonia may be caused by hypoxia, hypotension or anaesthesia. Since the antepartum cardiotoco-grams were normal, the placenta was grossly normal and the liquor was not meconium stained, it is unlikely that the fetus was hypoxic when delivered. Maternal hypotension is unlikely to have been the cause of fetal hypoxia, since the decrease in arterial pressure following induction was very brief, with recovery to the preoperative value at least 5 min before delivery. After controlled ventilation for 1 min the infant became pink with a normal heart rate, but remained floppy and unresponsive. Following a single dose of naloxone the baby became active, moved its limbs and attempted to cry. It is likely that the initially poor Apgar scores were the result of the narcotic effects of alfentanil.
At delivery, maternal and neonatal free drug concentrations were very similar (table II) . Therefore, the pharmacological effects might also be expected to be similar. Since the mother was anaesthetized, it is not possible to make direct comparison. However, the observed maternal alfentanil concentration (67 ng ml" 1 ) can be considered in the context of other detailed studies on the respiratory effects of alfentanil. The data obtained by O'Connor, Escarpa and Prys-Roberts (1983) suggest that a plasma concentration of 67 ng ml" 1 would be expected to decrease the gradient of a carbon dioxide response curve, but have no significant effect on ventilatory minute volume, frequency or PA COI . This contrasts with the apnoeic, hypotonic infant in our report. It appears that the neonate was much more susceptible to alfentanil than die mother.
It should be noted that after 1 h the neonatal plasma concentration had decreased to 12.5 ng ml"
1 . This modest change from the value measured at delivery is consistent with the 12-min delay between i.v. administration and delivery, during which extensive distribution would have occurred in both mother and baby. Indeed, the observed rate of decline probably indicates the rate of drug elimination.
CONCLUSIONS
The data lead to the following conclusions:
(1) The placenta presents no greater barrieT to alfentanil transfer than a simple dialysis membrane.
(2) The lower concentrations of alfentanil in neonatal plasma are not the result of slow placental transfer or rapid distribution in the fetus, but of the differing affinities of plasma proteins in maternal and neonatal blood.
(3) Equilibration of free drug across the placenta is rapid, so that the free neonatal concentration may be expected to follow the maternal concentration closely until delivery. (4) It should not be assumed that plasma concentrations in the neonate will decline after delivery as if the drug had just been given i.v., with the expectation that the effect will persist for a few minutes only. (5) While the use of moderate doses of alfentanil during anaesthesia for Caesarean section may be of benefit to the haemodynamically compromised mother, the baby should be expected to be severely depressed. Therefore, this technique would appear unsafe unless there are adequate facilities for the management of an apnoeic, anaesthetized infant.
